跳到正文
原文
Biotechnology Innovation Organization· @IAmBiotech · X·· 2026-10-14AI 评分20
AI 导读

2024年,Marci Pedrazzi McCue成为美国临床试验中首位接受CAR-T细胞疗法治疗多发性硬化症(MS)的患者。该试验由斯坦福大学医学院Jeffrey Dunn博士团队与Kyverna公司Naji Gehchan博士合作推进,旨在为MS患者探索新的治疗路径。

正文

In 2024, Marci Pedrazzi McCue became the first person in a U.S. clinical trial to receive an investigational CAR-T cell therapy for MS. For Marci, the courage to try something new brought hope for a future with greater certainty and independence.

Her journey reflects the work of Dr. Jeffrey Dunn and the Stanford University School of Medicine team, Dr. Naji Gehchan and @kyverna_us, and the countless others pushing science forward for everyone living with MS.

This is Marci's story: https://fightofourlives.com/stories/marci/

#FightofOurLives #MultipleSclerosis #Biotechnology

来源:Biotechnology Innovation Organization · x.com